title: Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis.
authors.forename: Domenico A
authors.initials: DA
authors.lastname: Restivo
authors.forename: Sara
authors.initials: S
authors.lastname: Lanza
authors.forename: Rosario
authors.initials: R
authors.lastname: Marchese-Ragona
authors.forename: Agostino
authors.initials: A
authors.lastname: Palmeri
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000150:complications*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000209:etiology*; D005774:Gastrostomy; D006801:Humans; D008406:Masseter Muscle / Q000187:drug effects*; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology; D009465:Neuromuscular Agents / Q000627:therapeutic use*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A